266 Tumour mutation burden (TMB) and efficacy outcomes in the phase III DANUBE study of advanced urothelial carcinoma (UC)Sophie Wildsmith, Jill Walker, Anne L’Hernault et al.|Regular and Young Investigator Award Abstracts|2020Cited by 7
Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched AnalysisWei Zhou, Lina Zhao, Guangjin Chai et al.|Cancers|2022Cited by 5
Current directions, conceptions and viewpoints on 2019‑nCoV (Review)Feng Xiao, Jianni Qi, Xiaoyu Xie et al.|Experimental and Therapeutic Medicine|2020Cited by 0
Characteristics of 1 062 patients with SARS in early stage in BeijingHaiying Lu, Demin Han, Xiaoyuan Xu et al.|World Chinese Journal of Digestology|2004Cited by 0